0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Dispersive viscosurgical devices demonstrate greater efficacy in protecting corneal endothelium in vitro

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          During phacoemulsification, the corneal endothelium is protected by an ophthalmic viscosurgical device (OVD). In this in vitro study, we assessed six different OVDs for their effectiveness in protecting the corneal endothelium.

          Methods and analysis

          Phacoemulsification was performed in cadaver eyes of young pigs. Five syringe units of six different OVDs were tested (Healon EndoCoat, Viscoat, Methylvisc, Healon, Healon GV, ProVisc). After surgery, the area of endothelium coated with OVD was determined in relation to the total endothelial surface. Additionally, an endothelial cell count was obtained. As a control, an endothelial cell count was obtained from freshly trephined corneas. Statistical analysis was performed using the Mann-Whitney U test and the Spearman correlation.

          Results

          The least postoperative endothelial coating and cell count were observed in the cohesive OVDs while the dispersive OVDs showed statistically significant higher values. Healon EndoCoat and Viscoat yielded a coating area of 86 (85–92)% and 85 (85-90)%, respectively. Endothelial cell count was highest in the two dispersive groups with 4065 (3928–4088) cells/mm 2 (Methylvisc) and 4032 (4015–4115) cells/mm 2 (Viscoat). Endothelial coating area and endothelial cell count correlated statistically significantly.

          Conclusion

          Dispersive OVDs from this study showed greater adherence to the endothelial surface than the cohesive ones. Furthermore, postoperative endothelial cell counts of corneas treated with dispersive OVDs were higher than of corneas treated with cohesive OVDs. Our in vitro results suggest that dispersive OVDs protect the corneal endothelium better during phacoemulsification than cohesive OVDs.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: not found

          Dispersive-cohesive viscoelastic soft shell technique.

          Based on their physical properties, ophthalmic viscoelastic agents can be divided into 2 groups: higher-viscosity cohesive and lower-viscosity dispersive. Higher-viscosity cohesive agents are best at creating and preserving space, while lower-viscosity dispersive agents are retained better in the anterior chamber and are capable of partitioning spaces. The viscoelastic soft shell technique maximizes the advantages and minimizes the disadvantages of both groups by using dispersive and cohesive agents together in sequence based on the desired surgical goal.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Dual staining of corneal endothelium with trypan blue and alizarin red S: importance of pH for the dye-lake reaction.

            Evaluation of corneal endothelial integrity by combined staining with the vital stain trypan blue and the intercellular stain alizarin red S provides a simple, quick technique for visualisation of both damaged and normal cells, thereby permitting the quantification of endothelial cell damage. Adjustment of the pH of the alizarin red S reagent to 4.2 is important for optimum dye-laking at the intercellular borders, and brief fixation with glutaraldehyde maintains the staining effect of both dyes.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Current status of corneal xenotransplantation

                Bookmark

                Author and article information

                Journal
                BMJ Open Ophthalmol
                BMJ Open Ophthalmol
                bmjophth
                bmjophth
                BMJ Open Ophthalmology
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2397-3269
                2019
                16 February 2019
                : 4
                : 1
                : e000227
                Affiliations
                [1] departmentThe David J Apple International Laboratory for Ocular Pathology , Heidelberg University Eye Clinic , Heidelberg, Germany
                Author notes
                [Correspondence to ] Prof. Gerd U Auffarth; gerd.auffarth@ 123456med.uni-heidelberg.de
                Author information
                http://orcid.org/0000-0002-3687-5082
                http://orcid.org/0000-0003-1065-4035
                Article
                bmjophth-2018-000227
                10.1136/bmjophth-2018-000227
                6440605
                2afb86e6-81a6-48b4-aba4-eec95ba158c1
                © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

                History
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100007316, Klaus Tschira Stiftung;
                Categories
                Original Article
                1506
                Custom metadata
                unlocked

                ophthalmic viscosurgical device,phacoemulsification,corneal endothelium protection

                Comments

                Comment on this article